146 related articles for article (PubMed ID: 29378024)
1. Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer.
Abe K; Kadoya N; Sato S; Hashimoto S; Nakajima Y; Miyasaka Y; Ito K; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Jingu K
J Radiat Res; 2018 Mar; 59(2):198-206. PubMed ID: 29378024
[TBL] [Abstract][Full Text] [Related]
2. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
3. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
4. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of a collapsed cone dose calculation algorithm for HDR Ir-192 of APBI treatments.
Terribilini D; Vitzthum V; Volken W; Frei D; Loessl K; van Veelen B; Manser P; Fix MK
Med Phys; 2017 Oct; 44(10):5475-5485. PubMed ID: 28750134
[TBL] [Abstract][Full Text] [Related]
6. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.
Beaulieu L; Carlsson Tedgren A; Carrier JF; Davis SD; Mourtada F; Rivard MJ; Thomson RM; Verhaegen F; Wareing TA; Williamson JF
Med Phys; 2012 Oct; 39(10):6208-36. PubMed ID: 23039658
[TBL] [Abstract][Full Text] [Related]
7. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.
Duque AS; Corradini S; Kamp F; Seidensticker M; Streitparth F; Kurz C; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Fonseca GP; Landry G
Radiat Oncol; 2020 Mar; 15(1):60. PubMed ID: 32151255
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Oncentra Brachy Advanced Collapsed cone Engine for a commercial (192)Ir source using heterogeneous geometries.
Ma Y; Lacroix F; Lavallée MC; Beaulieu L
Brachytherapy; 2015; 14(6):939-52. PubMed ID: 26403533
[TBL] [Abstract][Full Text] [Related]
9. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
10. Validation of the collapsed cone algorithm for HDR liver brachytherapy against Monte Carlo simulations.
Duque AS; van Wagenberg T; Seidensticker M; Streitparth F; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Paiva Fonseca G; Corradini S; Landry G
Brachytherapy; 2021; 20(4):936-947. PubMed ID: 34001415
[TBL] [Abstract][Full Text] [Related]
11. The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.
Hyer DE; Sheybani A; Jacobson GM; Kim Y
Brachytherapy; 2012; 11(6):515-20. PubMed ID: 22386723
[TBL] [Abstract][Full Text] [Related]
12. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
13. A review of dosimetric impact of implementation of model-based dose calculation algorithms (MBDCAs) for HDR brachytherapy.
Yousif YAM; Osman AFI; Halato MA
Phys Eng Sci Med; 2021 Sep; 44(3):871-886. PubMed ID: 34142317
[TBL] [Abstract][Full Text] [Related]
14. Experimental assessment of the Advanced Collapsed-cone Engine for scalp brachytherapy treatments.
Cawston-Grant B; Morrison H; Sloboda RS; Menon G
Brachytherapy; 2018; 17(2):489-499. PubMed ID: 29239813
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and radiobiological comparison of TG-43 and Monte Carlo calculations in
Peppa V; Pappas EP; Karaiskos P; Major T; Polgár C; Papagiannis P
Phys Med; 2016 Oct; 32(10):1245-1251. PubMed ID: 27720277
[TBL] [Abstract][Full Text] [Related]
16. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
Wang Z; Jaggernauth W; Malhotra HK; Podgorsak MB
Med Dosim; 2010; 35(4):269-73. PubMed ID: 19944586
[TBL] [Abstract][Full Text] [Related]
17. Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine.
Safigholi H; van Veelen B; Niatsetski Y; Song WY
Brachytherapy; 2018; 17(6):1030-1036. PubMed ID: 30181054
[TBL] [Abstract][Full Text] [Related]
18. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
19. Advanced dose calculation algorithm in superficial brachytherapy - the impact of tissue inhomogeneity on treatment plan dosimetry.
Szlag M; Kellas-Śleczka S; Wojcieszek P; Stankiewicz M; Cholewka A; Pruefer A; Krzysztofiak T; Lelek P; Stąpór-Fudzińska M; Ślosarek K
J Contemp Brachytherapy; 2021 Aug; 13(4):441-446. PubMed ID: 34484359
[TBL] [Abstract][Full Text] [Related]
20. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
Kim Y; Modrick JM; Pennington EC; Kim Y
J Appl Clin Med Phys; 2016 Mar; 17(2):405-426. PubMed ID: 27074463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
